A drug discovery company applying AI end to end, from generative protein design and large-scale data generation to picking targets and patients.
Xaira Therapeutics
Released March 17, 2026
Diffusion language model with 4.9 billion parameters that predicts genome-wide CRISPRi perturbation responses in single-cell transcriptomes.